Navigation Links
Kalidex Introduces Novel Fluoroquinolone, KPI-10, at the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
Date:9/6/2012

ae, including MDR and fluoroquinolone-resistant strains.

In addition, James Ge, M.D., Ph.D., president and chief scientific officer of Kalidex will deliver an oral presentation at the Poster Summary Session on Early New Antimicrobial Agents at 1:45 p.m. PDT on Sunday, September 9. The data to be presented reflect the substantial progress made at Kalidex on KPI-10 since the company's inception approximately 18 months ago, and cover a wide range of preclinical efficacy, PK, and toxicology data, as well as initial Phase 1 clinical data.

"The profile of KPI-10, particularly its activity against MDR strains of E. coli, N. gonorrhoeae, Acinetobacter species, streptococci and MRSA, suggests that successful development of this drug candidate may offer physicians a valuable treatment option," said Dr. Ge.  "Furthermore, our development of intravenous (IV) and oral formulations of KPI-10 is intended to allow for an IV-to-oral step down option, which is very desirable in today's healthcare settings. We look forward to completing Phase 1 clinical evaluation of KPI-10, and anticipate beginning our Phase 2 program in mid-2013."

The complete list of 24 abstracts on KPI-10 to be presented at ICAAC is available on the Kalidex website at www.kalidex.com.

About KPI-10
KPI-10 is a novel fluoroquinolone development candidate with a broad spectrum of activity against both gram-positive and gram-negative pathogens, including MDR strains and isolates resistant to currently available fluoroquinolones. KPI-10 is readily distinguished from existing fluoroquinolones because of its potent in vitro activity against gram-positive and gram-negative bacteria that are resistant to the currently-available fluoroquinolones (such as ciprofloxacin, levofloxacin, and moxifloxacin).

KPI-10 is a potent inhibitor of bacterial topoisomerases and is bactericidal.  The PK profile of KPI-10
'/>"/>

SOURCE Kalidex Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Zarbees Introduces a New Extra Strength Line of Natural Cough Products for Adults and Children 12+ in Time for Cough and Cold Season
2. Cool Containers Introduces a Non-Dry Ice Active Container for Frozen Shipments
3. Indegene Introduces TrialPedia 2.0 with Advantage Insights, Making It the Most Comprehensive Clinical Trial Analytics and Decision Support Platform for the Pharma Industry
4. FUJIFILM Introduces U.S.As First 24x30cm Wireless Detector At AHRA
5. FUJIFILM Introduces Flexible DR Room Offering
6. TI introduces the industrys first weigh scale and body composition analog front end
7. Vivant Skin Care Introduces 8% Mandelic Acid 3-in-1 Serum for Those New to Advanced Skin Care
8. Dr. Milton Owens, Well Known Bariatric Surgeon, Introduces Innovative "Inverted Corner Gastric Sleeve technique," An advanced technique that makes weight loss surgery even safer
9. Misonix Attends International Meeting On Advanced Spine Techniques (IMAST) - Introduces New Product
10. Zimmer Introduces First Porous Metal Interbody Implant for Lumbar Spine in the United States
11. PharmaNet/i3 Introduces PharmaNet/i3 Strategic Resourcing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... 2015  Epic Sciences announced today that the company ... castrate resistant prostate cancer patients, at the 2015 ... Oncology. This application expands the investigational utility of ... platform to characterize circulating tumor cell (CTC) genomic ... have heterogeneous clonal CTC populations harboring separate genetic ...
(Date:5/29/2015)... May 29, 2015 Educating the community ... Association for the Advancement of Wound Care (AAWC), ... support from AAWC,s corporate partners, the Association provides ... on the AAWC website at http://aawconline.org/education-for-the-generalist/ . ... pathway with links to various CME/CEU educational programs. ...
(Date:5/28/2015)... NEW YORK , May 28, 2015 ... billions developing new drugs and tests, and ... for the instruments that can assist them. This ... research publisher. Kalorama Information said instruments such as ... can assist in the identification of drug ...
Breaking Medicine Technology:Genetic Analysis of Single Circulating Tumor Cells Shows High Intra-patient Heterogeneity 2Genetic Analysis of Single Circulating Tumor Cells Shows High Intra-patient Heterogeneity 3The Association for the Advancement of Wound Care Educates the Public 2Report: Proteomics Research Market Reaches $1.6 Billion 2Report: Proteomics Research Market Reaches $1.6 Billion 3
... data,supporting the clinical development of telaprevir (VX-950), one ... the,treatment of hepatitis C virus (HCV) infection, will ... European Association for the,Study of the Liver (EASL) ... to telaprevir have been accepted for presentation,at the ...
... meeting of the European,Association for the Study of ... /PRNewswire-FirstCall/ --,Schering-Plough Corporation reaffirms its commitment to advancing,the ... (HCV),infection with several key data presentations at the ... 42nd annual meeting,in Barcelona, Spain, April 11-15. A ...
Cached Medicine Technology:Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 2Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 3Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 4Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 5Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 6Schering-Plough Addresses Major Milestones and Challenges in,Treatment of Patients With Chronic Hepatitis C 2Schering-Plough Addresses Major Milestones and Challenges in,Treatment of Patients With Chronic Hepatitis C 3Schering-Plough Addresses Major Milestones and Challenges in,Treatment of Patients With Chronic Hepatitis C 4Schering-Plough Addresses Major Milestones and Challenges in,Treatment of Patients With Chronic Hepatitis C 5Schering-Plough Addresses Major Milestones and Challenges in,Treatment of Patients With Chronic Hepatitis C 6Schering-Plough Addresses Major Milestones and Challenges in,Treatment of Patients With Chronic Hepatitis C 7
(Date:5/30/2015)... Clarkston, Metamora, Michigan (PRWEB) May 30, 2015 ... simple procedure to lighten or stop periods, without ... hysterectomy. This procedure can reduce or stop menstrual bleeding ... of the uterus (the part that causes the bleeding), ... 10 million women suffer from heavy menstrual bleeding. ...
(Date:5/30/2015)... 30, 2015 ProIntro Magnify contains 30 self-animating ... animations. Instantly add an elegant opening title to any ... range of clean design layouts. ProIntro Magnify is created exclusively ... extremely easy to use. Simply drag a preset into the ... and parameters in the Inspector window then watch as ProIntro ...
(Date:5/30/2015)... May 30, 2015 The Brain Fitness ... coordination with ONEgeneration Senior Enrichment Center, headed by 1Heart ... de Guzman and Brain Fitness Program Director Tee Barr. ... event learned that there are many ways to enrich ... showed the residents the different ways to overcome dementia ...
(Date:5/30/2015)... May 30, 2015 The iconic American ... will be hosting a new segment on Medical Malpractice. ... of medical malpractice in the health care field. , ... thousands of medical malpractice suits were filed, roughly only ... were settled out of court, while the remaining 30% ...
(Date:5/30/2015)... May 30, 2015 The IRS released ... 2015, announcing that, “criminals used taxpayer-specific data acquired from ... approximately 100,000 tax accounts through IRS’ “Get Transcript” application. ... and street address.” , “You don’t even have ... to think it was only a matter of time, ...
Breaking Medicine News(10 mins):Health News:Women's Excellence Now Provides NovaSure Treatment 2Health News:Announcing the release of ProIntro Magnify from Pixel Film Studios. 2Health News:1Heart Caregiver Services Brings Brain Fitness Education Seminar at ONEgeneration 2Health News:1Heart Caregiver Services Brings Brain Fitness Education Seminar at ONEgeneration 3Health News:IRS Attack Exemplifies the Compounding Dangers of Stolen Personal Data 2Health News:IRS Attack Exemplifies the Compounding Dangers of Stolen Personal Data 3Health News:IRS Attack Exemplifies the Compounding Dangers of Stolen Personal Data 4Health News:IRS Attack Exemplifies the Compounding Dangers of Stolen Personal Data 5
... DDS, and her staff will be racing to save lives ... of Baltimore,s 2009 Susan G. Komen Race for the Cure. ... Team Chincheck has raised more than $4,700 for breast cancer ... affected by breast cancer and witnessing their strength and courage ...
... some parents may be lukewarm to the H1N1 vaccination, ... of Southern California,s largest integrated, comprehensive healthcare organizations, reports ... access to the vaccine. In response, Lakeside Community Healthcare ... patients direct access to the information they need to ...
... ... tourism industry, announced the addition of certain providers of Sistemas Medicos Nacionales, S.A. de C.V. ... ... , a global health care company in the emerging medical tourism industry, announced the addition ...
... Oct. 14 Usinas,Siderurgicas de Minas Gerais S.A. - USIMINAS (OTC: USNZY) (BOVESPA: USIM3,USIM5, USIM6) ... Third Quarter 2009 Results Conference Call. Results will be, ... after Bovespa,s trading session., ... third quarter 2009 results, ...
... Peter Sheldon, Vice President of Operations for Coverall Health-Based ... will be a featured speaker at the Professional Retail ... on October 14-15 at The Fairmont Hotel in Dallas, ... Best in Your Business with Best Practices." Sheldon will ...
... Terumo ... the latest developments in its advanced DuraHeart™ Left-Ventricular Assist System at the 23rd Annual ... , ... Mich. (PRWEB) -- Terumo Heart, Inc., a wholly owned subsidiary of Terumo Corporation, today ...
Cached Medicine News:Health News:Team Chincheck Goes Miles for Smiles 2Health News:Leading Southern California Physicians Report Patient Fears About Complexities of Flu Season 2Health News:SIMNSA is added to the Satori Global Network™ in Mexico to Offer U.S. Employers Cross Border Health Benefit Options 2Health News:Webcast Alert: Usinas Siderurgicas de Minas Gerais S.A. - USIMINAS Announces Third Quarter 2009 Results Webcast 2Health News:Coverall Executive Peter Sheldon To Be Featured Speaker at PRSM Mid-Year Conference 2Health News:DuraHeart™ Third-Generation Left Ventricular Assist System Featured at 23rd Annual Meeting of the European Association for Cardio-thoracic Surgery 2Health News:DuraHeart™ Third-Generation Left Ventricular Assist System Featured at 23rd Annual Meeting of the European Association for Cardio-thoracic Surgery 3
CRP Liquid Conrtols level 2...
The AST method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of aspartate aminotransferase activity in serum or plasma...
Enzymatic Clearance assay for the in vitro quantitative determination of LDL-cholesterol in human serum and plasma....
Immunoturbidimetric assay for the quantitative in vitro determination of Lipoprotein (a) in human serum or plasma...
Medicine Products: